Seven Eight Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-15,097
Closed -$1.34M 743
2017
Q1
$1.34M Sell
15,097
-2,400
-14% -$197K 0.26% 137
2016
Q4
$1.24M Sell
17,497
-20,000
-53% -$1.49M 0.25% 152
2016
Q3
$2.96M Buy
+37,497
New +$3.2M 0.87% 21
2015
Q4
Sell
-13,397
Closed -$943K 761
2015
Q3
$943K Buy
+13,397
New +$1.1M 0.82% 19
2015
Q2
Sell
-497
Closed -$50K 742
2015
Q1
$50K Buy
497
+100
+25% +$10.1K 0.08% 286
2014
Q4
$40K Buy
+397
New +$39.6K 0.07% 287
2014
Q3
Sell
-4,100
Closed -$382K 751
2014
Q2
$382K Buy
+4,100
New +$358K 0.37% 74
2014
Q1
Sell
-2,000
Closed -$168K 596
2013
Q4
$168K Buy
+2,000
New +$163K 0.19% 173

Other funds holding MJN

Seven Eight Capital's MJN Position: Q2 2017 in Review

Seven Eight Capital sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 15,097 shares — an estimated $1.34M sold.

Seven Eight Capital first reported a position in MJN in Q4 2013 and held it in 8 quarters. The position peaked at $2.96M in Q3 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Seven Eight Capital reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Seven Eight Capital sold 15,097 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.34M.
  • Seven Eight Capital first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 8 quarters.
  • Seven Eight Capital's Mead Johnson Nutrition Company position peaked at $2.96M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Seven Eight Capital's 13F filing for Q2 2017, filed 10 Aug 2017.